Trial · NCT03713632
Participant flow35
How many started, completed or left each group, period by period.
1 to 20 of 35
Download this page as JSON| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Treatment Period 1 (Until Week 16) | STARTED | AIN457 Q2W | 181 | |
| Treatment Period 1 (Until Week 16) | STARTED | AIN457 Q4W | 180 | |
| Treatment Period 1 (Until Week 16) | STARTED | Placebo | 183 | |
| Treatment Period 1 (Until Week 16) | STARTED | Placebo - Re-randomized to AIN457 Q2W | 0 | |
| Treatment Period 1 (Until Week 16) | STARTED | Placebo - Re-randomized to AIN457 Q4W | 0 | |
| Treatment Period 1 (Until Week 16) | Full Analysis Set | AIN457 Q2W | 180 | |
| Treatment Period 1 (Until Week 16) | Full Analysis Set | AIN457 Q4W | 180 | |
| Treatment Period 1 (Until Week 16) | Full Analysis Set | Placebo | 183 | |
| Treatment Period 1 (Until Week 16) | Full Analysis Set | Placebo - Re-randomized to AIN457 Q2W | 0 | |
| Treatment Period 1 (Until Week 16) | Full Analysis Set | Placebo - Re-randomized to AIN457 Q4W | 0 | |
| Treatment Period 1 (Until Week 16) | COMPLETED | AIN457 Q2W | 170 | |
| Treatment Period 1 (Until Week 16) | COMPLETED | AIN457 Q4W | 169 | |
| Treatment Period 1 (Until Week 16) | COMPLETED | Placebo | 167 | |
| Treatment Period 1 (Until Week 16) | COMPLETED | Placebo - Re-randomized to AIN457 Q2W | 0 | |
| Treatment Period 1 (Until Week 16) | COMPLETED | Placebo - Re-randomized to AIN457 Q4W | 0 | |
| Treatment Period 1 (Until Week 16) | NOT COMPLETED | AIN457 Q2W | 11 | |
| Treatment Period 1 (Until Week 16) | NOT COMPLETED | AIN457 Q4W | 11 | |
| Treatment Period 1 (Until Week 16) | NOT COMPLETED | Placebo | 16 | |
| Treatment Period 1 (Until Week 16) | NOT COMPLETED | Placebo - Re-randomized to AIN457 Q2W | 0 | |
| Treatment Period 1 (Until Week 16) | NOT COMPLETED | Placebo - Re-randomized to AIN457 Q4W | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03713632/flow